Ritonavir Use in Human Immunodeficiency Virus-Positive Surgical Patients Is Not Associated with an Increase in Postoperative Critical Respiratory Events

Dermot P. Maher, Jacqueline Lee, Pauline Woo, Xiao Zhang, Paul F. White, Roya Yumul, Antonio Hernandez Conte

Research output: Contribution to journalArticlepeer-review

Abstract

This study evaluated whether highly active antiretroviral therapy for human immunodeficiency virus (HIV) including ritonavir is independently associated with increased critical respiratory events after general anesthesia with opioid analgesia. The impact of ritonavir on hepatic microsomal enzymes was considered due to the effect of these enzymes on opioid metabolism. Medical records of over 1900 patients were reviewed, and those of 941 patients met inclusion criteria and were analyzed. Chronic treatment with ritonavir was not associated with critical respiratory events in HIV-positive patients.

Original languageEnglish (US)
Pages (from-to)25-30
Number of pages6
JournalJournal of Pain and Palliative Care Pharmacotherapy
Volume30
Issue number1
DOIs
StatePublished - Jan 2 2016
Externally publishedYes

Keywords

  • Critical events
  • HIV
  • drug interaction
  • opioid
  • respiratory
  • ritonavir

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Ritonavir Use in Human Immunodeficiency Virus-Positive Surgical Patients Is Not Associated with an Increase in Postoperative Critical Respiratory Events'. Together they form a unique fingerprint.

Cite this